SEC Form 4 · accession 0001437749-17-010672
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine A. Sohn
Director
Period of report
Jun 1, 2017
Accepted (ET)
Jun 5, 2017 · 7:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)F1,F2 | — | Jun 1, 2017 | M | 4,286 | A | Jun 1, 2018 | — | Common Stock | 4,286 | 4,286 | D |
Explanation of responses
- F1The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F2Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.